Insider · CIK 0001678248

Kalb Michael Wayne

Reports to the SEC for 4 companies · CORAL GABLES, FL

sec.gov

Transactions

Companies

Filings

CIK

0001678248

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−13.7K sh	$31.50	−$430K	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−257K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−169K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−132K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−21.4K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−13.8K sh	—	—	0
2026-07-15	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−39.7K sh	—	—	0
2026-01-05	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,139 sh	—	—	15,745
2026-01-05	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,080 sh	—	—	13,665
2026-01-05	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,139 sh	—	—	632,903
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+6,894 sh	—	—	11,091
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,485 sh	—	—	8,606
2025-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−6,894 sh	—	—	640,042
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Financial Officer	AAward	+132K sh	—	—	607,235
2025-11-20	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+39.7K sh	—	—	646,936
2025-01-02	CPRXCATALYST PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+7,138 sh	—	—	7,138
2025-01-02	CPRXCATALYST PHARMACEUTICALS, INC.F Tax Payment	Chief Financial Officer	FTax Payment	−2,941 sh	—	—	4,197
2025-01-02	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−7,138 sh	—	—	475,699
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Options to purchase common stockA Award	Chief Financial Officer	AAward	+169K sh	—	—	462,155
2024-11-21	CPRXCATALYST PHARMACEUTICALS, INC. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+20.7K sh	—	—	482,837
2023-05-10	IPI Legacy Liquidation CoStock Option (right to buy)A Award	CFO	AAward	+175K sh	—	—	175,000
2023-05-10	IPI Legacy Liquidation CoRestricted Stock Units (RSUs)A Award	CFO	AAward	+47.5K sh	—	—	47,500
2023-02-24	CinCor Pharma, Inc.D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−202K sh	—	—	0
2023-02-24	CinCor Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	EVP & Chief Financial Officer	DDisposition to Issuer	−77.6K sh	—	—	0
2023-01-26	CinCor Pharma, Inc.A Award	EVP & Chief Financial Officer	AAward	+177K sh	—	—	202,437
2022-11-04	CinCor Pharma, Inc.A Award	EVP & Chief Financial Officer	AAward	+25.4K sh	—	—	25,437
2022-11-04	CinCor Pharma, Inc.Employee Stock Option (Right to Buy)A Award	EVP & Chief Financial Officer	AAward	+77.6K sh	—	—	77,615
2022-08-01	AMRNAMARIN CORP PLC\UKF Tax Payment	SVP and CFO	FTax Payment	−29.7K sh	$1.33	−$39.5K	337,314
2022-07-29	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+47.8K sh	—	—	301,882
2022-07-29	AMRNAMARIN CORP PLC\UKF Tax Payment	SVP and CFO	FTax Payment	−17.2K sh	$1.33	−$22.9K	284,662
2022-07-29	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−47.8K sh	—	—	95,533
2022-02-28	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+16.3K sh	—	—	256,960
2022-02-28	AMRNAMARIN CORP PLC\UKF Tax Payment	SVP and CFO	FTax Payment	−6,213 sh	$3.27	−$20.3K	250,747
2022-02-28	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−16.3K sh	—	—	16,333
2022-02-04	AMRNAMARIN CORP PLC\UK · Stock Option (Right to Buy)A Award	SVP and CFO	AAward	+132K sh	—	—	131,700
2022-02-04	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsA Award	SVP and CFO	AAward	+104K sh	—	—	103,700
2022-01-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+12.7K sh	—	—	245,944
2022-01-31	AMRNAMARIN CORP PLC\UKF Tax Payment	SVP and CFO	FTax Payment	−5,317 sh	$3.36	−$17.9K	240,627
2022-01-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−12.7K sh	—	—	0
2021-12-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+47.8K sh	—	—	258,590
2021-12-31	AMRNAMARIN CORP PLC\UKF Tax Payment	SVP and CFO	FTax Payment	−25.4K sh	$3.35	−$85K	233,211
2021-12-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−47.8K sh	—	—	95,533
2021-08-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+1,527 sh	—	—	206,537
2021-08-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+1,527 sh	—	—	208,064
2021-08-31	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+3,054 sh	—	—	211,118
2021-08-31	AMRNAMARIN CORP PLC\UKF Tax Payment	SVP and CFO	FTax Payment	−3,011 sh	$5.54	−$16.7K	208,107
2021-08-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−1,527 sh	—	—	0
2021-08-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−1,527 sh	—	—	0
2021-08-31	AMRNAMARIN CORP PLC\UK · Restricted Stock UnitsM Exercise/Conversion	SVP and CFO	MExercise/Conversion	−3,054 sh	—	—	0
2021-08-12	AMRNAMARIN CORP PLC\UKM Exercise/Conversion	SVP and CFO	MExercise/Conversion	+95K sh	$2.19	+$208K	300,010

Recent filings

Accepted (ET)
Jul 174
Kalb Michael Wayne0001161697-26-000178
SEC(opens sec.gov)
Jan 64
Kalb Michael Wayne0001161697-26-000022
SEC(opens sec.gov)
Nov 244
Kalb Michael Wayne0001161697-25-000418
SEC(opens sec.gov)
Jan 34
Kalb Michael Wayne0001161697-25-000026
SEC(opens sec.gov)
Nov 254
Kalb Michael Wayne0001161697-24-000478
SEC(opens sec.gov)

Companies

Address

355 ALHAMBRA CIRCLE SUITE 801

CORAL GABLES, FL, 33134